Patents by Inventor Jon L. Collins

Jon L. Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
    Publication number: 20110118261
    Abstract: The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and/or diabetes.
    Type: Application
    Filed: December 10, 2008
    Publication date: May 19, 2011
    Inventors: Scott Allen, William C. Blackwell, III, Eric Boros, Jon L. Collins, Don Hertzog, Xi Liang, John Ray, Steven Michael Reister, Vicente Samano, Ron Sherrill
  • Farnesoid X receptor agonists
    Patent number: 7319109
    Abstract: The invention relates to a compound of formula (I): wherein all variables are as defined herein and to pharmaceutical compositions, methods of using, and processes for preparing the same.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: January 15, 2008
    Assignee: Smith Kline Beecham Corporation
    Inventors: Sharon D Boggs, Jon L Collins, Stephen M Hyatt, Patrick R Maloney
  • Constitutive androstane receptor
    Patent number: 6579686
    Abstract: The present invention relates, in general, to nuclear receptors and, in particular, to the Constitutive Androstane Receptor (CAR; NR 1I3) and to a method of identifying ligands therefor.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: June 17, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jon L. Collins, Derek J. Parks
  • Constitutive androstane receptor
    Publication number: 20010055815
    Abstract: The present invention relates, in general, to nuclear receptors and, in particular, to the Constitutive Androstane Receptor (CAR; NR 1I3) and to a method of identifying ligands therefor.
    Type: Application
    Filed: March 22, 2001
    Publication date: December 27, 2001
    Inventors: Jon L. Collins, Derek J. Parks
  • 3'-Azido nucleoside compound
    Patent number: 5153318
    Abstract: The present invention relates to 3'-azido purine nucleosides and their use in medical therapy, particularly for the treatment of human immunodeficiency virus and hepatitis B virus infections, to methods for their preparation and to compositions containing them.
    Type: Grant
    Filed: October 2, 1990
    Date of Patent: October 6, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, George A. Freeman, Steven A. Short, Merrick R. Almond, Jon L. Collins